UNIGE document Scientific Article
previous document  unige:1837  next document
add to browser collection
Title

Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al
Authors
Wahl, Denis
Lecompte, Thomas Pierre
Bounameaux, Henri
Published in Arthritis and Rheumatism. 2008, vol. 58, no. 2, p. 635-6
Keywords Anti-Inflammatory Agents, Non-Steroidal/therapeutic use — Antibodies, Antiphospholipid/blood — Antiphospholipid Syndrome/drug therapy/epidemiology/immunology — Aspirin/therapeutic use — Humans — Risk Factors — Thrombosis/epidemiology/immunology/prevention & control
Identifiers
PMID: 18240250
Note With author reply (p. 636) - Comment on: Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, Unalp-Arida A, Vilela V, Yazici Y, Lockshin MD. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007 Jul;56(7):2382-91.
Full text
Article (Accepted version) (41 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Research groups Geneva Platelet Group (13)
La maladie thromboembolique veineuse (808)
Citation
(ISO format) 		WAHL, Denis, LECOMPTE, Thomas Pierre, BOUNAMEAUX, Henri. Need for additional trials of primary prophylaxis in patients with high-risk antiphospholipid antibody profiles: comment on the article by Erkan et al. In: Arthritis and Rheumatism, 2008, vol. 58, n° 2, p. 635-6. doi: 10.1002/art.23160 https://archive-ouverte.unige.ch/unige:1837

363 hits

0 download

Contact an author

Update request

Update

Deposited on : 2009-05-29

Export document
Format :
Citation style :